Cancer Research SABCS  EMT and Cancer Progression and Treatment
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 57, 3121-3125, August 1, 1997]
© 1997 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by McAllister, K. A.
Right arrow Articles by Wiseman, R. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by McAllister, K. A.
Right arrow Articles by Wiseman, R. W.

Characterization of the Rat and Mouse Homologues of the BRCA2 Breast Cancer Susceptibility Gene

Kimberly A. McAllister1, Astrid Haugen-Strano, Sarah Hagevik, Heather A. Brownlee, N. Keith Collins, P. Andrew Futreal, L. Michelle Bennett and Roger W. Wiseman

National Institute of Environmental Health Sciences, NIH, Research Triangle Park, North Carolina 27709 [K. A. M., A. H-S., S. H., H. A. B., N. K. C., L. M. B., R. W. W.], and Departments of Surgery, Obstetrics and Gynecology, and Genetics, Duke University Medical Center, Duke University, Durham, North Carolina 27710 [P. A. F.]

Inherited BRCA2 mutations confer profound susceptibility to human breast and ovarian cancer. The rat and mouse Brca2 homologues share 58% and 59% identity (72% similarity), respectively, with the human BRCA2 protein. The Brca2 proteins also share a potential nuclear localization signal (human codons 3263–3269) and a highly conserved large carboxyl region (77% identity, 86% similarity between human and rodents) that may represent important functional domains. At least six of eight previously described BRC repeats have been highly conserved in rats and mice. Expression studies demonstrate an 11–12 Kb transcript with rodent tissue-specific patterns of expression consistent with human BRCA2. These results will facilitate studies of Brca2 function during normal and neoplastic development.

1 To whom requests for reprints should be addressed, at Laboratory of Molecular Carcinogenesis, Mail Drop C4-06, National Institute of Environmental Health Sciences, Research Triangle Park, NC 27709. Phone: (919) 541-3229; Fax: (919) 541-3720; E-Mail: Mcallis2@niehs.nih.gov.

Received 2/21/97. Accepted 6/12/97.




This article has been cited by other articles:


Home page
Mol. Cell. Biol.Home page
A. R. Schoenfeld, S. Apgar, G. Dolios, R. Wang, and S. A. Aaronson
BRCA2 Is Ubiquitinated In Vivo and Interacts with USP11, a Deubiquitinating Enzyme That Exhibits Prosurvival Function in the Cellular Response to DNA Damage
Mol. Cell. Biol., September 1, 2004; 24(17): 7444 - 7455.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
C. Vissac-Sabatier, V. Coxam, P. Dechelotte, C. Picherit, M.-N. Horcajada, M.-J. Davicco, P. Lebecque, Y.-J. Bignon, and D. Bernard-Gallon
Phytoestrogen-Rich Diets Modulate Expression of Brca1 and Brca2 Tumor Suppressor Genes in Mammary Glands of Female Wistar Rats
Cancer Res., October 15, 2003; 63(20): 6607 - 6612.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
K. A. McAllister, L. M. Bennett, C. D. Houle, T. Ward, J. Malphurs, N. K. Collins, C. Cachafeiro, J. Haseman, E. H. Goulding, D. Bunch, et al.
Cancer Susceptibility of Mice with a Homozygous Deletion in the COOH-Terminal Domain of the Brca2 Gene
Cancer Res., February 1, 2002; 62(4): 990 - 994.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Yuan and Z. Shen
Interaction with BRCA2 Suggests a Role for Filamin-1 (hsFLNa) in DNA Damage Response
J. Biol. Chem., December 14, 2001; 276(51): 48318 - 48324.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
M. Takata, M. S. Sasaki, S. Tachiiri, T. Fukushima, E. Sonoda, D. Schild, L. H. Thompson, and S. Takeda
Chromosome Instability and Defective Recombinational Repair in Knockout Mutants of the Five Rad51 Paralogs
Mol. Cell. Biol., April 15, 2001; 21(8): 2858 - 2866.
[Abstract] [Full Text]


Home page
J. Med. Genet.Home page
J. PLASCHKE, T. COMMER, C. JACOBI, H. K SCHACKERT, and J. CHANG-CLAUDE
BRCA2 germline mutations among early onset breast cancer patients unselected for family history of the disease
J. Med. Genet., September 1, 2000; 37(9): 17e - 17.
[Full Text]


Home page
JNCI J Natl Cancer InstHome page
A.-M. Martin and B. L. Weber
Genetic and Hormonal Risk Factors in Breast Cancer
J Natl Cancer Inst, July 19, 2000; 92(14): 1126 - 1135.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
B. H. Spain, C. J. Larson, L. S. Shihabuddin, F. H. Gage, and I. M. Verma
Truncated BRCA2 is cytoplasmic: Implications for cancer-linked mutations
PNAS, November 23, 1999; 96(24): 13920 - 13925.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
L. Y. Marmorstein, T. Ouchi, and S. A. Aaronson
The BRCA2 gene product functionally interacts with p53 and RAD51
PNAS, November 10, 1998; 95(23): 13869 - 13874.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1997 by the American Association for Cancer Research.